Total Payments
$2,393
2024 Payments
$283.43
Companies
18
Transactions
132
Medicare Patients
5,941
Medicare Billing
$444,000
Payment Breakdown by Category
Food & Beverage$2,318 (96.9%)
Education$75.30 (3.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,318 | 130 | 96.9% |
| Education | $75.30 | 2 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $476.45 | 26 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $456.69 | 19 | $0 (2023) |
| Allergan, Inc. | $330.06 | 22 | $0 (2022) |
| ABBVIE INC. | $215.74 | 12 | $0 (2024) |
| Shire North American Group Inc | $200.50 | 11 | $0 (2018) |
| Alcon Vision LLC | $149.98 | 9 | $0 (2024) |
| Kala Pharmaceuticals, Inc. | $133.50 | 8 | $0 (2022) |
| Bausch & Lomb Americas Inc. | $76.08 | 4 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $74.54 | 4 | $0 (2017) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $74.32 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $283.43 | 15 | ABBVIE INC. ($79.56) |
| 2023 | $438.39 | 16 | Novartis Pharmaceuticals Corporation ($207.46) |
| 2022 | $355.93 | 21 | ABBVIE INC. ($104.25) |
| 2021 | $411.15 | 26 | Allergan, Inc. ($114.97) |
| 2020 | $314.62 | 18 | Sun Pharmaceutical Industries Inc. ($121.45) |
| 2019 | $223.62 | 15 | Sun Pharmaceutical Industries Inc. ($71.77) |
| 2018 | $141.72 | 10 | Shire North American Group Inc ($50.89) |
| 2017 | $224.15 | 11 | Shire North American Group Inc ($149.61) |
All Payment Transactions
132 individual payment records from CMS Open Payments — Page 3 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/31/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: DRY EYE | ||||||
| 01/19/2022 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Ocular | ||||||
| 12/14/2021 | Allergan, Inc. | VUITY (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/30/2021 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/26/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug), BromSite, Xelpros | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Ophthalmology | ||||||
| 10/19/2021 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/05/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/02/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug), BromSite, Xelpros | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: Ophthalmology | ||||||
| 08/30/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/17/2021 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/27/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/13/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Ocular | ||||||
| 07/06/2021 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/08/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/25/2021 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/11/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug), BromSite, Xelpros | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Ophthalmology | ||||||
| 05/04/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Ocular | ||||||
| 04/26/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 04/07/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug), LOTEMAX SM | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Ophthalmology | ||||||
| 04/07/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug), LOTEMAX SM | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Ophthalmology | ||||||
| 03/24/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug), BromSite, Xelpros | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Ophthalmology | ||||||
| 03/23/2021 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/16/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Ocular | ||||||
| 03/03/2021 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Glaucoma | ||||||
| 02/15/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug), BromSite, Xelpros | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,714 | 9,443 | $351,120 | $131,974 |
| 2022 | 10 | 1,246 | 9,063 | $256,185 | $93,256 |
| 2021 | 10 | 1,406 | 8,618 | $323,220 | $104,865 |
| 2020 | 11 | 1,575 | 11,398 | $456,015 | $113,906 |
Total Patients
5,941
Total Services
38,522
Medicare Billing
$444,000
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 711 | 897 | $161,460 | $65,925 | 40.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 211 | 341 | $44,330 | $18,811 | 42.4% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 53 | 69 | $34,500 | $15,480 | 44.9% |
| 92250 | Photography of the retina | Office | 2023 | 322 | 363 | $27,225 | $8,464 | 31.1% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 85 | 85 | $19,975 | $8,107 | 40.6% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Office | 2023 | 43 | 6,032 | $34,500 | $5,473 | 15.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 118 | 118 | $7,670 | $2,698 | 35.2% |
| 92082 | Exam of visual field with intermediate testing | Office | 2023 | 66 | 67 | $5,025 | $1,949 | 38.8% |
| 76519 | Ultrasound scan to determine eye length and lens power | Office | 2023 | 48 | 74 | $4,070 | $1,699 | 41.7% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Office | 2023 | 12 | 1,350 | $7,500 | $1,586 | 21.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $2,625 | $1,003 | 38.2% |
| 92134 | Imaging of retina | Office | 2023 | 30 | 32 | $2,240 | $779.93 | 34.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 588 | 696 | $125,280 | $50,631 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 142 | 272 | $35,360 | $16,293 | 46.1% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Office | 2022 | 49 | 7,561 | $42,500 | $6,849 | 16.1% |
| 92250 | Photography of the retina | Office | 2022 | 220 | 242 | $18,150 | $5,744 | 31.6% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 19 | 19 | $11,000 | $5,026 | 45.7% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 38 | 38 | $8,930 | $3,157 | 35.4% |
| 92133 | Imaging of optic nerve | Office | 2022 | 87 | 87 | $5,655 | $2,072 | 36.6% |
| 76519 | Ultrasound scan to determine eye length and lens power | Office | 2022 | 42 | 84 | $4,620 | $1,719 | 37.2% |
| 92082 | Exam of visual field with intermediate testing | Office | 2022 | 41 | 42 | $3,150 | $1,137 | 36.1% |
| 92134 | Imaging of retina | Office | 2022 | 20 | 22 | $1,540 | $629.01 | 40.8% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 687 | 847 | $152,460 | $63,339 | 41.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 168 | 243 | $28,530 | $13,973 | 49.0% |
| 66984 | Removal of cataract with insertion of lens, simple | Office | 2021 | 45 | 6,930 | $87,950 | $7,539 | 8.6% |
About Dr. C Mcquaig, MD
Dr. C Mcquaig, MD is a Ophthalmology healthcare provider based in Milledgeville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215999818.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. C Mcquaig, MD has received a total of $2,393 in payments from pharmaceutical and medical device companies, with $283.43 received in 2024. These payments were reported across 132 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,318).
As a Medicare-enrolled provider, Mcquaig has provided services to 5,941 Medicare beneficiaries, totaling 38,522 services with total Medicare billing of $444,000. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Milledgeville, GA
- Active Since 04/06/2006
- Last Updated 03/09/2011
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1215999818
Products in Payments
- XIIDRA (Drug) $658.49
- LUMIGAN (Drug) $344.20
- Cequa (Drug) $283.23
- VUITY (Drug) $134.98
- INVELTYS (Drug) $133.50
- XELPROS (Drug) $101.77
- BROMSITE (Drug) $91.45
- PROLENSA (Drug) $79.86
- Rocklatan (Drug) $69.41
- VYZULTA (Drug) $55.34
- XDEMVY (Drug) $52.87
- TRAVATAN Z (Drug) $34.54
- RESTASIS (Drug) $34.24
- BESIVANCE (Drug) $31.82
- rhopressa (Drug) $29.58
- PROKERA (Device) $28.56
- TYRVAYA (Drug) $27.08
- OXERVATE (Drug) $24.68
- Precision 7 (Device) $22.32
- MIEBO (Drug) $22.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.